Cefuracetime (CED0164971)

Record Information
Version1.0
Creation Date2026-03-31 20:37:18 UTC
Update Date2026-05-20 19:26:45 UTC
SynCED IDCED0164971
Secondary Accession Numbers
  • CHEM057786
Identification
Common NameCefuracetime
ClassSmall Molecule
Description
Cefuracetime is an organic compound with the formula C17H17N3O8S1. Cefuracetime belongs to the beta lactams, a subclass of lactams within the organic compounds. It is classified as an organoheterocyclic compound. This substance is found in or released from one recorded source: healthcare, pharmaceuticals & veterinary products (Antibiotics). Recorded exposure routes for cefuracetime include oral and inhalation.
Contaminant TypeNot Available
Chemical Structure
SynonymsNot Available
Chemical FormulaC17H17N3O8S1
Average Molecular MassNot Available
Monoisotopic Mass423.074 g/mol
CAS Registry Number39685-31-9
IUPAC NameNot Available
Traditional NameNot Available
SMILESNot Available
InChI IdentifierInChI=1S/C17H17N3O8S/c1-8(21)28-6-9-7-29-16-12(15(23)20(16)13(9)17(24)25)18-14(22)11(19-26-2)10-4-3-5-27-10/h3-5,12,16H,6-7H2,1-2H3,(H,18,22)(H,24,25)/b19-11-/t12-,16-/m1/s1
InChI KeyYBHZVPYSEUQIII-DYJQDLSISA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
SpectraNot Available
Toxicity Profile
Toxicity Values
Toxicity ValueOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalToxicity RatingReference
5315.0 Log mg/kg [3000:9500]RatLD50oralpredictedNot AvailableNot Available
Toxicity / Toxin ClassNot Available
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
CEDs000306Antibiotics?Antibiotics are synthetic or semi-synthetic compounds used to treat bacterial infections in humans and animals.Healthcare, pharmaceuticals & veterinary productsNot Available
CEDs000605Pest Repellants?Pest repellents, often formulated from synthetic chemicals, are widely used to protect crops from insect infestations and other pests.Agriculture & land managementNot Available
CEDs000606Plant Growth Regulators?Plant Growth Regulators (PGRs) are synthetic chemicals designed to influence the growth and development of plants.Agriculture & land managementNot Available
CEDs000696Nanotechnology?Nanotechnology involves the manipulation of materials at the molecular or atomic level, typically within the range of 1 to 100 nanometers.Industrial manufacturing & chemical processingNot Available
Pathways
0 pathwaysPathway Source: PathBank

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Click to view 3D structureSolute carrier family 22 member 6Q4U2R8HumansPredicted (SEA)
Prediction Confidence Score
0.374
Applicability Domain
0.494
Statistical Significance
1.60e-04
Supporting Reference Compounds
26
E-value
1.24559
Click to view 3D structureOrganic anion transporter 3Q8TCC7HumansPredicted (SEA)
Prediction Confidence Score
0.374
Applicability Domain
0.494
Statistical Significance
2.90e-04
Supporting Reference Compounds
20
E-value
2.25763
Solute carrier family 22 member 11 structureClick to view 3D structureSolute carrier family 22 member 11Q9NSA0HumansPredicted (SEA)
Prediction Confidence Score
0.373
Applicability Domain
0.494
Statistical Significance
9.00e-05
Supporting Reference Compounds
9
E-value
0.700643
Click to view 3D structureBeta-lactamaseB2ZTR6Acinetobacter baumanniiPredicted (SEA)
Prediction Confidence Score
0.33
Applicability Domain
0.494
Statistical Significance
3.00e-05
Supporting Reference Compounds
3
E-value
0.233548
Click to view 3D structureADC-11D6NSM8Acinetobacter baumanniiPredicted (SEA)
Prediction Confidence Score
0.33
Applicability Domain
0.494
Statistical Significance
3.00e-05
Supporting Reference Compounds
3
E-value
0.233548
Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 structureClick to view 3D structureCarboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1Q9GZU7HumansPredicted (SEA)
Prediction Confidence Score
0.32
Applicability Domain
0.481
Statistical Significance
0.0033
Supporting Reference Compounds
128
E-value
25.6124
DNA (cytosine-5)-methyltransferase 1 structureClick to view 3D structureDNA (cytosine-5)-methyltransferase 1P26358HumansPredicted (SEA)
Prediction Confidence Score
0.304
Applicability Domain
0.481
Statistical Significance
0.0071
Supporting Reference Compounds
116
E-value
55.4286
Click to view 3D structureStreptokinase AP10520Streptococcus pyogenes serotype M1Predicted (SEA)
Prediction Confidence Score
0.302
Applicability Domain
0.424
Statistical Significance
0.0199
Supporting Reference Compounds
425
E-value
155.076
Speckle-type POZ protein structureClick to view 3D structureSpeckle-type POZ proteinO43791HumansPredicted (SEA)
Prediction Confidence Score
0.301
Applicability Domain
0.301
Statistical Significance
8.00e-05
Supporting Reference Compounds
1
E-value
0.622794
Click to view 3D structureSolute carrier family 12 member 5Q63633Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.229
Applicability Domain
0.229 Low confidence
Statistical Significance
0.0111
Supporting Reference Compounds
1
E-value
86.4905
72 kDa type IV collagenase structureClick to view 3D structure72 kDa type IV collagenaseP08253HumansPredicted (SEA)
Prediction Confidence Score
0.217
Applicability Domain
0.27 Low confidence
Statistical Significance
0.4054
Supporting Reference Compounds
400
E-value
3156.4
Click to view 3D structureAlpha-1A adrenergic receptorP43140Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.217
Applicability Domain
0.226 Low confidence
Statistical Significance
0.2508
Supporting Reference Compounds
208
E-value
1952.69
Click to view 3D structureAlpha-1B adrenergic receptorP35368HumansPredicted (SEA)
Prediction Confidence Score
0.217
Applicability Domain
0.226 Low confidence
Statistical Significance
0.3578
Supporting Reference Compounds
298
E-value
2785.13
Sodium/iodide cotransporter structureClick to view 3D structureSodium/iodide cotransporterQ63008Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.216
Applicability Domain
0.216 Low confidence
Statistical Significance
0.0311
Supporting Reference Compounds
1
E-value
242.422
Alpha-1A adrenergic receptor structureClick to view 3D structureAlpha-1A adrenergic receptorP35348HumansPredicted (SEA)
Prediction Confidence Score
0.215
Applicability Domain
0.226 Low confidence
Statistical Significance
0.4308
Supporting Reference Compounds
376
E-value
3354.06
Click to view 3D structureProbable nicotinate-nucleotide adenylyltransferaseP65502Staphylococcus aureus (strain N315)Predicted (SEA)
Prediction Confidence Score
0.215
Applicability Domain
0.27 Low confidence
Statistical Significance
0.077
Supporting Reference Compounds
51
E-value
599.439
Click to view 3D structureD(2) dopamine receptorP61169RatPredicted (SEA)
Prediction Confidence Score
0.213
Applicability Domain
0.215 Low confidence
Statistical Significance
0.4615
Supporting Reference Compounds
528
E-value
3592.82
Click to view 3D structureAlpha-1D adrenergic receptorP23944Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.213
Applicability Domain
0.215 Low confidence
Statistical Significance
0.1674
Supporting Reference Compounds
105
E-value
1303.51
Prothrombin structureClick to view 3D structureProthrombinP00734HumansPredicted (SEA)
Prediction Confidence Score
0.213
Applicability Domain
0.229 Low confidence
Statistical Significance
0.4196
Supporting Reference Compounds
331
E-value
3266.24
26S proteasome non-ATPase regulatory subunit 14 structureClick to view 3D structure26S proteasome non-ATPase regulatory subunit 14O00487HumansPredicted (SEA)
Prediction Confidence Score
0.211
Applicability Domain
0.27 Low confidence
Statistical Significance
0.0396
Supporting Reference Compounds
39
E-value
308.127
Estrogen receptor beta structureClick to view 3D structureEstrogen receptor betaQ92731HumansPredicted (SEA)
Prediction Confidence Score
0.209
Applicability Domain
0.229 Low confidence
Statistical Significance
0.2751
Supporting Reference Compounds
174
E-value
2141.4
Dual specificity protein phosphatase 3 structureClick to view 3D structureDual specificity protein phosphatase 3P51452HumansPredicted (SEA)
Prediction Confidence Score
0.208
Applicability Domain
0.313
Statistical Significance
0.2394
Supporting Reference Compounds
147
E-value
1863.79
Click to view 3D structureAlpha-1B adrenergic receptorP15823Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.208
Applicability Domain
0.226 Low confidence
Statistical Significance
0.2175
Supporting Reference Compounds
130
E-value
1693.45
Click to view 3D structureAlpha-1D adrenergic receptorP25100HumansPredicted (SEA)
Prediction Confidence Score
0.207
Applicability Domain
0.215 Low confidence
Statistical Significance
0.408
Supporting Reference Compounds
258
E-value
3176.48
Click to view 3D structureThymidine kinase 2D3ZGQ2Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.207
Applicability Domain
0.207 Low confidence
Statistical Significance
0.011
Supporting Reference Compounds
1
E-value
86.0234
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available